While patients with either RGS9/R9AP-associated retinopathy or oligocone trichromacy have very similar clinical phenotypes, we highlight the utility of cellular imaging in both effectively distinguishing between these conditions and determining the potential for therapeutic intervention. The gene discussed is RGS9; the disease is oligocone trichromacy.